Intimation about Schedule of Analyst / Institutional Investor Meeting on June 5, 2026

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.2%1-day move

₹17095.00

prior close

₹17102.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.3+0.3-0.7-0.4-1.2-1.0-1.1-1.3-1.2-1.1+0.7+9.6——

Up moveDown movePending

AI summary

Neuland Laboratories has informed exchanges that its management will participate in the BOFA Healthcare Tour in Hyderabad on June 5, 2026. The meeting will include both group and one-on-one sessions with analysts and institutional investors. This is a routine regulatory disclosure under SEBI LODR Regulation 30. The company notes that the schedule and participant list may change due to exigencies. The filing was made on May 31, 2026.

Likely market impact

This is a standard investor relations activity with neutral impact. It signals management engagement with institutional investors but contains no material corporate news, earnings updates, or guidance that would directly affect the stock.